August 15, 2026 08:39 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Ajit Doval breaks silence on Operation Sindoor in Discovery’s explosive new docuseries | Rahul Gandhi's 'mock hug' taunt sparks row; Centre stresses 'mutual respect' with Italy | Delhi on high alert: Bomb threat to High Court, airport and multiple locations ahead of I-Day | ‘Who are they to interfere?’: CJI Surya Kant slams Bar Council of India over NALSAR students’ enrolment row | 'Shows how low Congress has sunk': BJP slams Rahul Gandhi over Modi foreign policy jibe | From guns to glamour: Former women Maoists walk the ramp in Chhattisgarh | Netaji row: Suvendu Adhikari govt strips BJP MP Anant Maharaj of state honour | Sukhbir Badal attacked by Nihang Sikh with kirpan at Maharashtra gurdwara; assailant detained | ‘If you cannot do it, we will pass an order’: Supreme Court’s final warning to Centre on food labels | ‘Time to move on’: Bombay HC sends strong message in Vijay Mallya-bank dispute
Mansukh Mandaviya | WHO
Mansukh Mandaviya | WHO

Health Minister Mansukh Mandaviya meets WHO chief scientist to discuss Covaxin approval

| @indiablooms | Aug 13, 2021, at 05:47 am

New Delhi/IBNS: Union Health Minister Mansukh Mandaviya on Thursday met World Health Organisation (WHO) Chief Scientist Dr Soumya Swaminathan to hold discussion over the global health body's approval for Bharat Biotech's COVID-19 vaccine Covaxin.

He also informed that the WHO chief scientist lauded India's effort in combating COVID-19.

In a tweet, Mandaviya said: "Held a meeting with Dr Soumya Swaminathan, Chief Scientist of @WHO. We had a productive discussion on WHO's approval of @BharatBiotech''s COVAXIN. @DoctorSoumya also appreciated India's efforts for the containment of #COVID19."

Earlier in May, Bharat Biotech had said regulatory approvals for its indigenously developed Covid-19 vaccine are in process in more than 60 countries including the US, Brazil and Hungary.

Emergency use authorisations (EUA) have been obtained from 13 countries with more to follow, Bharat Biotech had informed.

It had also submitted an application to the WHO to get a EUL (Emergency Use Listing) for indigenously developed Covid-19 vaccine Covaxin and regulatory approvals are expected by Jul-Sept 2021.

The indigenous Covaxin vaccine is co-developed by Bharat Biotech and ICMR, Dr Raches said the Government placed an advanced purchase order of rupees 1500 crore and this will help our company to increase our risk appetite and that is why we are expanding to Bangalore and Gujarat.
 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.